Recent news
Abreos Biosciences' next generation multiplex approach to Covid-19 antibody testing is mentioned in Bioworld
May 7, 2020
Abreos Biosciences invited to pitch at MedTech Innovator / BARDA COVID 19 Online Pitch Event
April 29, 2020
Abreos Biosciences Launches Laboratory Developed Test for Precision Dose Monitoring of Natalizumab (Tysabri).
August 28, 2018
Abreos Biosciences presented at the Biocom Global Partnering Life Sciences Partnering Conference.
March 1, 2018
Abreos Biosciences won Silicon Valley's Most Promising Company Award at the Precision Medicine World Conference 2018.
January 24, 2018
Abreos Biosciences competed as a finalist in the MedTech Innovator 2017 Competition.
September 26, 2017
Abreos Biosciences was selected as one of 20 companies to participate in the MedTech Innovator Accelerator.
May 30, 2017
The Journal of Precision Medicine featured Abreos Biosciences in its recent article, "Ready for a Dose of Reality?"
May 30, 2017
Abreos Biosciences' participation in the MedTech Innovator pitch competition was featured in BIOCOM's coverage of the HealthTech LA event.
March 9, 2017
Abreos Biosciences has been selected as one of MedTech Innovator's Top 100 emerging medical technology companies.
March 4, 2017
Bradley Messmer, the CEO of Abreos Biosciences, Will Participate as a Finalist in the Swimming with Sharks Competition on Wednesday, February 24th and Will Present on Point-of-Care Diagnostics for Personalized Dosing of Biologics on Friday, February 22nd.
February 22-24, 2017
CEO Bradly Messmer Presented on the San Diego Biotech Industry Panel during the Cancer Moonshot Panel Summit Hosted by the American Cancer Society and Biocom
December 12, 2016
Immune System, Unleashed by Cancer Therapies, Can Attack Organs
December 3, 2016
Bradley Messmer, the CEO of Abreos Biosciences, Presented Peptide Mimics that Allow for Therapeutic Drug Monitoring of Biologic Drugs at AAPS 2016
November 14, 2016
Abreos Biosciences Announces The Formation Of A French Subsidiary, Abreos France, And A Research Collaboration With The Institut Paoli-Calmettes For Therapeutic Drug Monitoring Of Biologics
October 3, 2016
Biocom’s 9th Annual DeviceFest Conference: Congrats to Abreos Biosciences
August 30, 2016
Biotech Startup Stories: Abreos Biosciences
August 22, 2016
Triton Technology Fund Announces Their Investment in Abreos Biosciences
June 28, 2016
Abreos Biosciences and True Diagnostics Sign Collaboration Agreement for Novel Biologics Tests
March 8, 2016
Abreos Biosciences is selected as one of four finalists to compete at the 2015 VC Pitchfest organized by the San Diego Venture Group
December 3, 2015
Bradley Messmer, founder and CEO of Abreos Biosciences, is speaking at the Molecular Tumor Board Meeting about precision dosing of biologic drugs and point-of-care testing
August 26, 2015
Abreos Biosciences earns the "Cool Companies" designation by the San Diego Venture Group
June 27, 2015
Bradley Messmer, founder and CEO of Abreos Biosciences, discusses the future of nanotechnology at the Rock Stars of Innovation Summit
June 10, 2015
Abreos Biosciences is developing partnerships during the Second Edition of BIOCOM / FRENCH BIOBEACH Trade Delegation to the South of France
April 27, 2015
Abreos Biosciences is featured in Nature News for impressive performance at NIH I-Corps
March 25, 2015
Abreos Biosciences is awarded a Phase I SBIR grant to develop a rapid lateral flow based assay for endotoxin detection
March 1, 2015
Abreos Biosciences is awarded a Phase I SBIR grant to develop MuDPAQ, a sequencing-based proteomics platform using DeNAno technology
Januray 15, 2015
Abreos Biosciences selected as one of 20 companies to participate in the inaugural I-Corps program sponsored by the NIH
October 7, 2014
Abreos Biosciences is awarded a Phase I STTR grant from the National Cancer Institute to develop lateral flow immunoassays for therapeutic drug dosing
September 23, 2014
Bradley Messmer reveals to the Times of San Diego how Abreos Biosciences provides a solution for the rapid identification of counterfeit pharmaceuticals
June 12, 2014
Abreos Biosciences graduates from the CONNECT Springboard program and wins the CONNECT Capital Competition
April 23, 2014
Abreos Biosciences is awarded a Phase I SBIR grant from the National Cancer Institute to develop lateral flow immunoassays for monoclonal antibody authentication
April 15, 2014
Abreos Biosciences wins the prestigious Tech Coast Angels Quick Pitch “Best Content” award
September 26, 2013
Abreos Biosciences Announces Research Collaboration with FDA-CDER
March 26, 2019
Abreos Biosciences’ founder Bradley Messmer discusses how to protect patients from counterfeit medication on The Empowered Patient radio show
September 13, 2013